HB2550 amends Section 5-5.2 of the Illinois Public Aid Code to change Medicaid reimbursement for nursing facilities that have disclosed themselves as Alzheimer’s special care units under the Alzheimer’s Disease and Related Dementias Special Care Disclosure Act. Beginning January 1, 2026, the bill requires the applicable rate to be multiplied by 5 for those facilities, and it directs the Department of Healthcare and Family Services to update facility status for rate-setting purposes each January 1.
The bill is narrowly focused on long-term care payment policy, but it sits within a broader nursing-facility reimbursement section that already governs Medicaid rates, PDPM methodology, staffing add-ons, quality payments, and other adjustments. Its practical effect would be to substantially increase Medicaid reimbursement for nursing homes that publicly identify as Alzheimer’s special care units, likely affecting state Medicaid spending and the revenue of qualifying facilities.
Impact
HB2550 would amend the Illinois Public Aid Code’s nursing facility payment provisions by creating a new reimbursement multiplier for facilities that disclose Alzheimer’s special care unit status. The Department of Healthcare and Family Services would need to verify and update facility status annually for rate-setting, and Medicaid payment calculations for qualifying facilities would increase beginning January 1, 2026. The bill would directly affect nursing facilities serving residents with Alzheimer’s disease or related dementias, while also increasing the state’s Medicaid expenditure obligations for those providers.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate, support, or opposition in the available materials. Based on the bill’s subject matter and caption, the measure appears intended to support specialized dementia care providers through higher reimbursement. The absence of recorded action makes the overall legislative sentiment indeterminate from the supplied record.
Contention
The main policy issue is whether a fivefold rate increase for disclosed Alzheimer’s special care units is an appropriate and targeted use of Medicaid funds. Potential supporters would likely include nursing facilities that operate dementia-specific units and advocates for residents with Alzheimer’s disease, while potential critics could include fiscal watchdogs or budget-minded lawmakers concerned about cost, verification, and whether the multiplier is too generous relative to other nursing facility rate adjustments. Another possible point of contention is the disclosure requirement itself, since the bill ties eligibility to formal status under the special care disclosure law and requires annual departmental updates.